Subcommittee on Crime and Terrorism

Researching the Potential Medical Benefits and Risks of Marijuana

Type: Subcommittee Hearing

Date: Wednesday, July 13th, 2016

Time: 02:30pm

Location: Dirksen Senate Office Building Room 226

Presiding: Chairman Graham

Download Executive Business Meeting Results

Download Executive Business Meeting Results

Download Executive Business Meeting Results

Member Statements

Ranking Member Chuck Grassley

R, IA

Download Member Statement
Senator Patrick Leahy

D, VT

Download Member Statement
Senator Orrin Hatch

Republican, Utah

Download Member Statement

Panel I

Kirsten Gillibrand

Senator

State of New York
Cory Booker

Senator

State of New Jersey

Panel II

Susan Weiss, Ph.D.

Director
Division of Extramural Research
National Institute on Drug Abuse
National Institutes of Health
Bethesda, MD

Download Testimony

Weiss Responses to Blumenthal Questions for the Record
Douglas Throckmorton, M.D.

Deputy Center Director for Regulatory Programs
Food and Drug Administration
Silver Spring, MD

Download Testimony

Panel III

Daniele Piomelli, Ph.D., Pharm.D.

Professor of Anatomy and Neurobiology
University of California, Irvine
Irvine, CA

Download Testimony

Piomelli Responses to Blumenthal Questions for the Record
Stuart Gitlow, M.D.

Executive Director
Annenberg Physician Training Program in Addictive Disease
American Society of Addiction Medicine
Woonsocket, RI

Download Testimony

Gitlow Responses to Blumenthal Questions for the Record
D. Linden Barber, J.D.

Partner

Quarles and Brady, LLP

Indianapolis, IN

Download Testimony

Barber response to Blumenthal Questions for the Record

To see the latest version of this page, please click here.